Rachel A. Ross

Rachel A. Ross

Auto-generated profile, based on publicly available information

Rachel A. Ross

Department of Neuroscience, Albert Einstein College of Medicine 1 , Bronx, NY, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2018 in eLife
Verified
Journal Article
Open access
RRRachel A Ross
Rachel A Ross
SLSilvia Leon
Silvia Leon
JMJoseph C Madara
Joseph C Madara
DSDanielle Schafer
Danielle Schafer
CFChrysanthi Fergani
Chrysanthi Fergani
VNVictor M Navarro
Victor M Navarro
Pituitary adenylate cyclase activating polypeptide (PACAP, Adcyap1) is a neuromodulator implicated in anxiety, metabolism and reproductive behavior. PACAP global knockout mice have decreased fertility and PACAP modulates LH release. However, its source and role at the hypothalamic level remain unknown. We demonstrate that PACAP-expressing neurons of the ventral premamillary nucleus of the hypothalamus (PMVPACAP) project to, and make direct contact with, kisspeptin neurons in the arcuate and AVPV/PeN nuclei and a subset of these neurons respond to PACAP exposure. Targeted deletion of PACAP from the PMV through stereotaxic virally mediated cre- injection or genetic cross to LepR-i-cre mice with Adcyap1fl/fl mice led to delayed puberty onset and impaired reproductive function in female, but not male, mice. We propose a new role for PACAP-expressing neurons in the PMV in the relay of nutritional state information to regulate GnRH release by modulating the activity of kisspeptin neurons, thereby regulating reproduction in female mice.

7 January 2020 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
RRRachel A. Ross
Rachel A. Ross
SHSusanne S. Hoeppner
Susanne S. Hoeppner
SHSamantha N. Hellberg
Samantha N. Hellberg
EOEmily B. O’day
Emily B. O’day
PRPeter L. Rosencrans
Peter L. Rosencrans
NSNaomi M. Simon
Naomi M. Simon

2 January 2013 in BMC International Health and Human Rights
Verified
Journal Article
Open access
PDF file
JKJ Daniel Kelly
J Daniel Kelly
MBM Bailor Barrie
M Bailor Barrie
RRRachel A Ross
Rachel A Ross
BTBrian A Temple
Brian A Temple
LMLina Moses
Lina Moses
DBDaniel G Bausch
Daniel G Bausch
Poor quality housing is an infringement on the rights of all humans to a standard of living adequate for health. Among the many vulnerabilities of those without adequate shelter is the risk of disease spread by rodents and other pests. One such disease is Lassa fever, an acute and sometimes severe viral hemorrhagic illness endemic in West Africa. Lassa virus is maintained in the rodent Mastomys natalensis, commonly known as the “multimammate rat,” which frequently invades the domestic environment, putting humans at risk of Lassa fever. The highest reported incidence of Lassa fever in the world is consistently in the Kenema District of Sierra Leone, a region that was at the center of Sierra Leone’s civil war in which tens of thousands of lives were lost and hundreds of thousands of dwellings destroyed. Despite the end of the war in 2002, most of Kenema’s population still lives in inadequate housing that puts them at risk of rodent invasion and Lassa fever. Furthermore, despite years of health education and village hygiene campaigns, the incidence of Lassa fever in Kenema District appears to be increasing. We focus on Lassa fever as a matter of human rights, proposing a strategy to improve housing quality, and discuss how housing equity has the potential to improve health equity and ultimately economic productivity in Sierra Leone. The manuscript is designed to spur discussion and action towards provision of housing and prevention of disease in one of the world’s most vulnerable populations.

16 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
VCVictor Castro
Victor Castro
RRRachel A Ross
Rachel A Ross
SMSean MJ McBride
Sean MJ McBride
RPRoy H Perlis
Roy H Perlis
Objective: Absent a vaccine or any established treatments for the novel and highly infectious coronavirus-19 (COVID-19), rapid efforts to identify potential therapeutics are required. We sought to identify commonly prescribed medications that may be associated with lesser risk of morbidity with COVID-19 across 6 Eastern Massachusetts hospitals. Design: In silico cohort using electronic health records from individuals evaluated in the emergency department between March 4, 2020 and July 12, 2020. Setting: Emergency department and inpatient settings from 2 academic medical centers and 4 community hospitals. Participants: All individuals presenting to an emergency department and undergoing COVID-19 testing. Main Outcome or Measure: Inpatient hospitalization; documented requirement for mechanical ventilation. Results: Among 7,360 individuals with COVID-19 positive test results by PCR, 3,693 (50.2%) were hospitalized in one of 6 hospitals. In models adjusted for sociodemographic features and overall burden of medical illness, medications significantly associated with diminished risk for hospitalization included ibuprofen and sumatriptan. Among individuals who were hospitalized, 962(26.0%) were admitted to the intensive care unit and 608 (16.5%) died; ibuprofen and naproxen were also more commonly prescribed among individuals not requiring intensive care. Conclusions: These preliminary findings suggest that electronic health records may be applied to identify medications associated with lower risk of morbidity with COVID-19, but larger cohorts will be required to address the substantial problem of confounding by indication, such that extreme caution is warranted in interpreting nonrandomized results. Trial Registration: None Summary Boxes: Section 1: What is already known on this topic: Absent a vaccine or any established treatments for the novel and highly infectious coronavirus-19 (COVID-19), rapid efforts to identify potential therapeutics are required. Section 2: What this study adds: This cohort study across 6 hospitals identified medications enriched among individuals positive for COVID-19 who are less likely to experience adverse outcomes including hospitalization, intensive care, or death.

1 November 2016 in Harvard Review of Psychiatry
Verified
Journal Article
Closed access
RRRachel A. Ross
Rachel A. Ross
YMYael Mandelblat-Cerf
Yael Mandelblat-Cerf
AVAnne M.J. Verstegen
Anne M.J. Verstegen
Anorexia nervosa (AN) is a psychiatric illness with minimal effective treatments and a very high rate of mortality. Understanding the neurobiological underpinnings of the disease is imperative for improving outcomes and can be aided by the study of animal models. The activity-based anorexia rodent model (ABA) is the current best parallel for the study of AN. This review describes the basic neurobiology of feeding and hyperactivity seen in both ABA and AN, and compiles the research on the role that stress-response and reward pathways play in modulating the homeostatic drive to eat and to expend energy, which become dysfunctional in ABA and AN.

25 June 2023 in Physiology & Behavior
Verified
Journal Article
Open access
RRRachel A Ross
Rachel A Ross
AKAngela Kim
Angela Kim
PDPriyanka Das
Priyanka Das
YLYan Li
Yan Li
YCYong Kee Choi
Yong Kee Choi
KRKerry J Ressler
Kerry J Ressler
Melanocortin 4 receptor (MC4R) activity in the hypothalamus is crucial for regulation of metabolism and food intake. The peptide ligands for the MC4R are associated with feeding, energy expenditure, and also with complex behaviors that orchestrate energy intake and expenditure, but the downstream neuroanatomical and neurochemical targets associated with these behaviors are elusive. In addition to strong expression in the hypothalamus, the MC4R is highly expressed in the medial prefrontal cortex, a region involved in executive function and decision-making. Using viral techniques in genetically modified male mice combined with molecular techniques, we identify and define the effects on feeding behavior of a novel population of MC4R expressing neurons in the infralimbic (IL) region of the cortex. Here, we describe a novel population of MC4R-expressing neurons in the IL of the mouse prefrontal cortex that are glutamatergic, receive input from melanocortinergic neurons, and project to multiple regions that coordinate appetitive responses to food-related stimuli. The neurons are stimulated by application of MC4R-specific peptidergic agonist, THIQ. Deletion of MC4R from the IL neurons causes increased food intake and body weight gain and impaired executive function in simple food-related behavior tasks. Together, these data suggest that MC4R neurons of the IL play a critical role in the regulation of food intake in male mice.